- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03512509
Comparison of Low GI and High GI Potatoes in Relation to Satiety (POSAT) (POSAT)
October 10, 2018 updated by: Anne Birgitte Raben
Comparison of Low GI and High GI Potatoes in Relation to Satiety - a Randomised Control Trial
The study is a single-blind, randomised crossover study, investigating how a high glycaemic potato affects satiety in humans compared to a low glycaemic potato.
This is done to shed further light on the discussion about whether potatoes with a high glycaemic index increases the risk of overweight and obesity and thus indirectly type 2 diabetes and cardiovascular disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The POSAT study follows a single-blinded randomized crossover design.
Each subject will have two separate intervention days with at least a six-day washout period in between.
On the two intervention days the subjects will be randomized into receiving a breakfast containing isocaloric amounts of either low or high GI potatoes.
VAS will be measured 5 minutes before the meal, immediately after the meal is consumed and in intervals of 30 minutes thereafter until 2,5 hours after the initial meal.
After this the subjects will be served a standardized homogenous ad libitum meal.
The amount of food consumed will be registered.
The subjects will be asked to fast for 8-10 hours prior to the trial days and abstain from vigorous physical activity and alcohol consumption for 2 days prior to each trial day.
The trial will be conducted over a total of 8 days with 5-6 study subjects pr.
trial day.
The trial days will be spread out over a total of 2 weeks to allow for a 1-week washout period between trial days for each subject.
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Frederiksberg, Denmark, 1958
- University of Copenhagen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Healthy men
- Body mass index (BMI) 18-27 kg/m2
- Age 18-40 years
- Signed informed consent
- Able to eat 500 grams of potato for breakfast
Exclusion Criteria:
- Chronic diseases as diabetes, cardiovascular diseases or other chronic metabolic diseases, which could affect the results.
- Use of daily prescription medicine (mild analgesics and antihistamines are allowed).
- Use of medicine or dietary supplements that can affect ones appetite one month before the start of the study.
- Smoking or have been smoking or using any nicotine products (gum or e-cigarette) within the last 3 months. Irregular smoking is allowed.
- Elite athletes defined as doing >10 hours of strenuous physical activity per week.
- Participation in other clinical studies <1 month before or during the study.
- Inability, physically or psychologically, to comply with the procedures required by the study protocol. Judged by the investigators.
- Any food allergies.
- Weight change of ±3 kg from screening to the trial has been conducted.
- Inability to complete the trial within 3 months after screening.
- Unable to fast 8-10 hours before the trial days.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: A
Low glycaemic potato
|
The Carisma potato variety is used as the low glycaemic index potato.
|
|
Experimental: B
High glycaemic potato
|
The Arizona potato variety is used as the high glycaemic index potato.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective satiety evaluation
Time Frame: 3 hours
|
Visual Analogue Scale (100mm) filled out by subjects to describe satiety.
|
3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hunger, fullness, and prospective food consumption
Time Frame: 3 hours
|
Visual Analogue Scale (100mm) filled out by subjects to describe hunger, fullness, and prospective food consumption.
|
3 hours
|
|
Energy consumed in Ad libitum meal
Time Frame: 30 minutes
|
Energy intake (kJ) meassured by weighing of food consumed during a ad libitum meal.
|
30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Anne Raben, Professor, Department of Nutrition, Sports and Exercise, University of Copenhagen
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 5, 2018
Primary Completion (Actual)
April 30, 2018
Study Completion (Actual)
August 20, 2018
Study Registration Dates
First Submitted
March 15, 2018
First Submitted That Met QC Criteria
April 18, 2018
First Posted (Actual)
April 30, 2018
Study Record Updates
Last Update Posted (Actual)
October 11, 2018
Last Update Submitted That Met QC Criteria
October 10, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- B344
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.